Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

UNKNOWN

The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy

Lead Sponsor:

Advanced Magnetic Research Institute International

Conditions:

Diabetic Neuropathies

Pain

Eligibility:

All Genders

18-79 years

Phase:

PHASE3

Brief Summary

This study is intended to demonstrate that exposure to a high intensity, DC electromagnetic field, as supplied by the investigational device known as the Molecular Magnetic Energizer (MME), will creat...

Detailed Description

Diabetic peripheral neuropathy (DPN) affects up to 1/2 of diabetics, both type I and II. It contributes to limb amputation, and can cause painful symptoms which are difficult to treat. Application of ...

Eligibility Criteria

Inclusion

  • Subjects with diabetic peripheral neuropathy in feet with associated pain/discomfort.
  • Stable and controlled diabetes with hemoglobin A1c level less than 9.0% at entry into the study. Diabetes type I or type II accepted.
  • Subjects must be able to read English.

Exclusion

  • Pacemakers, defibrillators, aneurysm clips, cochlear implants, any metallic particles in eyes or ferromagnetic metal shrapnel, projectile or implant in body.
  • Pregnant women
  • Concurrent neuropathy not due to diabetes.
  • Unstable cardiac disease or uncontrolled blood pressure.
  • Renal failure
  • Active hepatitis
  • History of nerve injury to lower extremities.
  • History of spinal surgery or total knee arthroplasty
  • Current malignancy
  • Alcoholism
  • History of stroke
  • Seizure disorder
  • Current use of long acting narcotic medication
  • Skin ulceration or breakdown of the lower extremities
  • Peripheral vascular disease sufficient to cause extremity pain at rest.

Key Trial Info

Start Date :

July 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2008

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00134524

Start Date

July 1 2005

End Date

January 1 2008

Last Update

July 10 2007

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

AMRI Arizona

Tucson, Arizona, United States, 85711

2

AMRI MI

Sterling Heights, Michigan, United States, 48313

3

AMRI NC

Mocksville, North Carolina, United States, 27208

4

Amri NW Oh

Toledo, Ohio, United States, 48313